Metabolon’s New Liver Fibrosis, Kidney Function Discovery Panels Reveal Disease Mechanisms
Metabolon, a global provider in metabolomics solutions, announced the launch of its new Liver Fibrosis and Kidney Function Discovery Panels.
Read MorePosted by Andy Lundin | Oct 17, 2023 | Diagnostic Technologies, Kidney Disease |
Metabolon, a global provider in metabolomics solutions, announced the launch of its new Liver Fibrosis and Kidney Function Discovery Panels.
Read MorePosted by Chris Wolski | Dec 23, 2022 | Cancer, Sequencing Systems |
Researchers have made an advancement in genetic testing that allows for more accurate prediction of individual’s increased cancer risk.
Read MorePosted by Andy Lundin | May 31, 2022 | Kidney Disease |
Researchers established the inherited condition, TULP3-related ciliopathy, which causes kidney and liver failure in children and adults.
Read MorePosted by Andy Lundin | Apr 18, 2022 | Heart Disease |
About one in four adults has a liver disorder that is a risk factor for heart disease, according to the American Heart Association.
Read MorePosted by Chris Wolski | Jul 2, 2025 | Molecular Diagnostics |
Seegene has launched STAgora, a next-gen infectious disease analytics platform providing real-time, AI-driven insights.
Read More